Claus Dieter Bischoff

Title: The Innovations of Claus Dieter Bischoff

Introduction

Claus Dieter Bischoff is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for oral administration. His work is recognized for its potential impact on treating various disorders.

Latest Patents

Claus Dieter Bischoff holds a patent for a pharmaceutical composition that includes a non-bile farnesoid X receptor (FXR) agonist. The patent details a composition comprising 2-[(1R,3R,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid, or a pharmaceutically acceptable salt thereof, along with at least one lipid excipient. This invention is aimed at providing a solution for FXR mediated disorders and includes a process for preparing the pharmaceutical composition.

Career Highlights

Claus Dieter Bischoff is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to focus on innovative pharmaceutical solutions that address critical health issues. His expertise and dedication to research have positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Claus has collaborated with talented professionals, including Sonali Bose and Geoffrey Gogniat. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Claus Dieter Bischoff's contributions to pharmaceutical innovation highlight the importance of research and development in healthcare. His patent and work at Novartis AG demonstrate his commitment to improving treatment options for patients.